trouble is ppl expect and want quick returns and in some cases...

trouble is ppl expect and want quick returns and in some cases rightly so.... this isn't the only biotech that isn't loved......we have some companies with 2-3 P3 studies around 90m MC and some without any phase 1 with 90m market cap....

I am holder of those..... sometimes it's confusing but it's what it is....

key is to view biotech investment as a 3-4 year play for good returns .... get in early.... forget about it for few years and returns will start to flow.....

this strategy only works if you have patience and extra cash around which u can invest for long term

I think most impressive is how they moved from ore clinical to P2 in such a short space in oncology .... trust management will deliver returns... I am in at .2 for 100k shares.... so total of 20k AUD.... won't invest more as for me 20k is a sweet figure if I am in early and look to exit around 100k.... happy to wait and watch